BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21390060)

  • 1. Cellular and molecular response of human macrophages exposed to Aggregatibacter actinomycetemcomitans leukotoxin.
    Kelk P; Abd H; Claesson R; Sandström G; Sjöstedt A; Johansson A
    Cell Death Dis; 2011 Mar; 2(3):e126. PubMed ID: 21390060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both leukotoxin and poly-N-acetylglucosamine surface polysaccharide protect Aggregatibacter actinomycetemcomitans cells from macrophage killing.
    Venketaraman V; Lin AK; Le A; Kachlany SC; Connell ND; Kaplan JB
    Microb Pathog; 2008 Sep; 45(3):173-80. PubMed ID: 18573331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-1beta secretion induced by Aggregatibacter (Actinobacillus) actinomycetemcomitans is mainly caused by the leukotoxin.
    Kelk P; Claesson R; Chen C; Sjöstedt A; Johansson A
    Int J Med Microbiol; 2008 Jul; 298(5-6):529-41. PubMed ID: 17888725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggregatibacter actinomycetemcomitans leukotoxin: a powerful tool with capacity to cause imbalance in the host inflammatory response.
    Johansson A
    Toxins (Basel); 2011 Mar; 3(3):242-59. PubMed ID: 22069708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggregatibacter actinomycetemcomitans leukotoxin: from threat to therapy.
    Kachlany SC
    J Dent Res; 2010 Jun; 89(6):561-70. PubMed ID: 20200418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abundant secretion of bioactive interleukin-1beta by human macrophages induced by Actinobacillus actinomycetemcomitans leukotoxin.
    Kelk P; Claesson R; Hänström L; Lerner UH; Kalfas S; Johansson A
    Infect Immun; 2005 Jan; 73(1):453-8. PubMed ID: 15618184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspase 1 involvement in human monocyte lysis induced by Actinobacillus actinomycetemcomitans leukotoxin.
    Kelk P; Johansson A; Claesson R; Hänström L; Kalfas S
    Infect Immun; 2003 Aug; 71(8):4448-55. PubMed ID: 12874324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathogenicity of the oral opportunistic pathogen Actinobacillus actinomycetemcomitans.
    Henderson B; Nair SP; Ward JM; Wilson M
    Annu Rev Microbiol; 2003; 57():29-55. PubMed ID: 14527274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggregatibacter (Actinobacillus) actimycetemcomitans leukotoxin and human periodontitis - A historic review with emphasis on JP2.
    Tsai CC; Ho YP; Chou YS; Ho KY; Wu YM; Lin YC
    Kaohsiung J Med Sci; 2018 Apr; 34(4):186-193. PubMed ID: 29655406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaerobic neutrophil-dependent killing of Actinobacillus actinomycetemcomitans in relation to the bacterial leukotoxicity.
    Johansson A; Sandström G; Claesson R; Hänström L; Kalfas S
    Eur J Oral Sci; 2000 Apr; 108(2):136-46. PubMed ID: 10768727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggregatibacter actinomycetemcomitans: virulence of its leukotoxin and association with aggressive periodontitis.
    Åberg CH; Kelk P; Johansson A
    Virulence; 2015; 6(3):188-95. PubMed ID: 25494963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of serotype, leukotoxin gene type and lysogeny in Actinobacillus actinomycetemcomitans to periodontal disease status.
    Barretto Tinoco EM; Stevens R; Haubek D; Lai CH; Balachandran S; Preus H
    Eur J Oral Sci; 1997 Aug; 105(4):310-7. PubMed ID: 9298362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody reactive with Actinobacillus actinomycetemcomitans leukotoxin in early-onset periodontitis patients.
    Califano JV; Pace BE; Gunsolley JC; Schenkein HA; Lally ET; Tew JG
    Oral Microbiol Immunol; 1997 Feb; 12(1):20-6. PubMed ID: 9151640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic antibodies to the leukotoxin of the oral pathogen Actinobacillus actinomycetemcomitans correlate negatively with stroke in women.
    Johansson A; Johansson I; Eriksson M; Ahrén AM; Hallmans G; Stegmayr B
    Cerebrovasc Dis; 2005; 20(4):226-32. PubMed ID: 16123541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Virulence of Aggregatibacter actinomycetemcomitans Through the Analysis of Leukotoxin.
    Nagasawa T; Kato S; Furuichi Y
    Methods Mol Biol; 2021; 2210():185-193. PubMed ID: 32815139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretion of RTX leukotoxin by Actinobacillus actinomycetemcomitans.
    Kachlany SC; Fine DH; Figurski DH
    Infect Immun; 2000 Nov; 68(11):6094-100. PubMed ID: 11035711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationships between leukotoxin production, growth rate and the bicarbonate concentration in a toxin-production-variable strain of Actinobacillus actinomycetemcomitans.
    Ohta H; Miyagi A; Kato K; Fukui K
    Microbiology (Reading); 1996 Apr; 142 ( Pt 4)():963-970. PubMed ID: 8936323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of synthetic histatin 5 on leukotoxin from Actinobacillus actinomycetemcomitans.
    Murakami Y; Xu T; Helmerhorst EJ; Ori G; Troxler RF; Lally ET; Oppenheim FG
    Oral Microbiol Immunol; 2002 Jun; 17(3):143-9. PubMed ID: 12030965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond the specific plaque hypothesis: are highly leukotoxic strains of Actinobacillus actinomycetemcomitans a paradigm for periodontal pathogenesis?
    Guthmiller JM; Lally ET; Korostoff J
    Crit Rev Oral Biol Med; 2001; 12(2):116-24. PubMed ID: 11345522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral pathogenesis of Aggregatibacter actinomycetemcomitans.
    Gholizadeh P; Pormohammad A; Eslami H; Shokouhi B; Fakhrzadeh V; Kafil HS
    Microb Pathog; 2017 Dec; 113():303-311. PubMed ID: 29117508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.